Cory Abate-Shen on Bladder Cancer Modeling

Cory Abate-Shen, PhD
Published: Monday, Jan 11, 2016



Cory Abate-Shen, PhD, research faculty, Columbia Urology, Columbia University Medical Center, discusses the challenges of bladder cancer modeling.

In order to develop mouse models, it is necessary to know where the tumor originates. However, this is not currently well understood in bladder cancer, says Abate-Shen.

Researchers are working to understand the key alterations that contribute to bladder cancer tumors. Recent advancements in genomic analysis have given researchers more tools, and it is now understood that P53 is a key player in bladder cancer, says Abate-Shen.


Cory Abate-Shen, PhD, research faculty, Columbia Urology, Columbia University Medical Center, discusses the challenges of bladder cancer modeling.

In order to develop mouse models, it is necessary to know where the tumor originates. However, this is not currently well understood in bladder cancer, says Abate-Shen.

Researchers are working to understand the key alterations that contribute to bladder cancer tumors. Recent advancements in genomic analysis have given researchers more tools, and it is now understood that P53 is a key player in bladder cancer, says Abate-Shen.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Key Questions for the Use of Immunotherapy Throughout the Disease Continuum for NSCLC in an Era of Rapid DevelopmentSep 29, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing GlioblastomaSep 29, 20182.0
Publication Bottom Border
Border Publication
x